Adoptive immunotherapy with IL-2 results in the loss of delayed-type hypersensitivity responses and the development of immediate hypersensitivity to recall antigens
- 1 February 1989
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 50 (2) , 184-195
- https://doi.org/10.1016/0090-1229(89)90127-x
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Two types of mouse helper T-cell clone: Implications for immune regulationImmunology Today, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- B-Cell Stimulatory Factor-1/Interleukin 4Annual Review of Immunology, 1987
- Usual interstitial pneumonitis is a T-cell alveolitisClinical Immunology and Immunopathology, 1986
- Functional characterization of T lymphocytes propagated from human lung carcinomasClinical Immunology and Immunopathology, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Histamine-induced suppressor cells of lymphocyte mitogenic responseCellular Immunology, 1981
- Delayed Hypersensitivity Skin Testing. II. Clinical Correlates and AnergyThe Journal of Infectious Diseases, 1974
- EFFECT OF LOCAL ADRENALINE AND HISTAMINE ON TUBECULIN REACTIONSAllergy, 1953